Skip to main content
SpringerLink
Log in

Molecular/cell engineering approach to autocrine ligand control of cell function

  • Research Articles
  • Published:
Annals of Biomedical Engineering Aims and scope Submit manuscript

Abstract

Tissue engineering, along with other modern celland tissue-based health care technologies, depends on successful regulation of cell function by molecular means, including pharmacological agents, materials, and genetics. This regulation is generally mediated by cell receptor/ligand interactions providing primary targets for molecular intervention. While regulatory ligands may often be exogenous in nature, in the categories of endocrine and paracrine hormone systems, they are being increasingly appreciated as crucial in local control of cell and tissue function. Improvements in design of health care technologies involving autocrine ligand interactions with cell receptors should benefit from increased qualitative and quantitative understanding of the kinetic and transport processes governing these interactions. In this symposium paper we offer a concise overview of our recent efforts combining molecular cell biology and engineering approaches to increase the understanding of how molecular and cellular parameters may be manipulated for improved control of cell and tissue function regulated by autocrine ligands.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Akira, S., T. Hirano, T. Taga, and T. Kishimoto. Biology of multifunctional cytokines: IL-6 and related molecules (IL-1 and TNF).FASEB J. 4:2860–2867, 1990.

    PubMed  CAS  Google Scholar 

  2. Alcalay, M., D. Zingrilli, P. P. Pandolfi, L. Longo, A. Mencarelli, A. Glacomucciet al. Translocation breakpoint of acute promyelocytic leukemia lies within the retinoic acid α locus.Proc. Natl. Acad. Sci. USA 88:1977–1981, 1991.

    Article  PubMed  CAS  Google Scholar 

  3. Baselga, J., and J. Mendelsohn. The epidermal growth factor receptor as a target for therapy in breast carcinoma.Breast Canc. Res. Treat. 29:127–138, 1994.

    Article  CAS  Google Scholar 

  4. Bennett, N. T., and G. S. Schultz. Growth factors and wound healing, II: Role in normal and chronic wound healing.Am. J. Surg. 166:74–81, 1993.

    Article  PubMed  CAS  Google Scholar 

  5. Broder, S., ed. Molecular Foundations of Oncology. Baltimore: Williams & Wilkins, 1991.

    Google Scholar 

  6. Campion, S. R., D. R. Tadaki, and S. K. Niyogi. Evaluation of the role of electrostatic residues in human epidermal growth factor by site-directed mutagenesis and chemical modification.J. Cell Biochem. 50:35–42, 1992.

    Article  PubMed  CAS  Google Scholar 

  7. Cannon, W. B.. Organization for physiological homeostasis.Physiol. Rev. 9:399–431, 1929.

    Google Scholar 

  8. Castilla, A., J. Prieto, and N. Fausto. Transforming growth factors beta 1 and alpha in chronic liver disease.N. Engl. J. Med. 324:933–940, 1991.

    Article  PubMed  CAS  Google Scholar 

  9. Cima, L. G., D. Ingber, J. Vacanti, and R. Langer. Hepatocyte culture on biodegradable polymeric substrates.Biotech. Bioeng. 38:145–158, 1991.

    Article  CAS  Google Scholar 

  10. Cima, L. G., and R. Langer. Engineering human tissue.Chem. Eng. Prog. June:46–54, 1993.

    Google Scholar 

  11. Cima, L. G., J. Vacanti, C. Vacanti, D. Ingber, D. Mooney, and R. Langer. Tissue engineering by cell transplantation using degradable polymer substrates.J. Biomech. Eng. 113:143–151, 1991.

    PubMed  CAS  Google Scholar 

  12. Claret, E., J.-C. Renversez, X. Zheng, T. Bonnefoix, and J.-J. Sotto. Valid estimation of IL-2 secretion by PHA-stimulated T-cell clones absolutely requires the use of anti-CD25 monoclonal antibody to prevent IL-2 consumption.Immunol. Lett. 33:179–186, 1992.

    Article  PubMed  CAS  Google Scholar 

  13. Derynck, R. The physiology of transforming growth factor alpha.Adv. Canc. Res. 58:27–52, 1992.

    CAS  Google Scholar 

  14. Edelman, E. R., E. Mathiowitz, R. Langer, and M. Klagsbrun. Controlled and modulated release of basic fibroblast growth factor.Biomaterials 12:619–626, 1991.

    Article  PubMed  CAS  Google Scholar 

  15. Edgington, S. Angiogenic and angiostatic drugs: Reshaping biotech's future.Bio/tech. 10:981–985, 1992.

    Article  CAS  Google Scholar 

  16. Flaumenhaft, R., and D. B. Rifkin. The extracellular regulation of growth factor action.Mol. Biol. Cell 3:1057–1065, 1992.

    PubMed  CAS  Google Scholar 

  17. Forsten, K. E., and D. A. Lauffenburger. Autocrine ligand binding to cell receptors: Mathematical analysis of competition by solution decoys.Biophys. J. 61:518–529, 1992.

    PubMed  CAS  Google Scholar 

  18. Forsten, K. E., and D. A. Lauffenburger. Interrupting autocrine ligand/receptor binding: Comparison between receptor blockers and ligand decoys.Biophys. J. 63:857–861, 1992.

    Article  PubMed  CAS  Google Scholar 

  19. Forsten, K. E., and D. A. Lauffenburger. Probability of autocrine ligand capture by cell surface receptors: implications for ligand secretion measurements.J. Comp. Biol. 1:15–23, 1994.

    CAS  Google Scholar 

  20. French, A. R., Sudlow, G., Wiley, H. S., and Lauffenburger, D. A. Postendocytic trafficking of EGF/EGF-receptor complexes is mediated through saturable and specific endosomal interactions.J. Biol. Chem. 269:15749–15755, 1994.

    PubMed  CAS  Google Scholar 

  21. Harris, E. D.. Rheumatoid arthritis: pathophysiology and implications for therapy.N. Engl. J. Med. 322:1277–1289, 1990.

    Article  PubMed  Google Scholar 

  22. Hodgson, J.. Receptor screening and the search for new pharmaceuticals.Bio/tech. 10:973–980, 1993.

    Article  Google Scholar 

  23. Hoffman, A. S. Molecular bioengineering of biomaterials in the 1990s and beyond: A growing liaison of polymers with molecular biology.Artif. Organs 16:43–49, 1992.

    Article  PubMed  CAS  Google Scholar 

  24. Ingber, D. E. The riddle of morphogenesis: A question of solution chemistry or molecular cell engineering?Cell 75: 1249–1252, 1993.

    Article  PubMed  CAS  Google Scholar 

  25. King, R. J., M. B. Jones, and M. Parviz. Regulation of lung cell proliferation by polypeptide growth factors.Am. J. Physiol. 257:L23-L38, 1989.

    PubMed  CAS  Google Scholar 

  26. Knauer, D. J., H. S. Wiley, and D. D. Cunningham. Relationship between EGF-receptor occupancy and mitogenic response: Quantitative analysis using a steady-state model system.J. Biol. Chem. 259:5623–5631, 1984.

    PubMed  CAS  Google Scholar 

  27. Kubuju, D. A., and L. G. Fine. Physiology and cell biology update: Polypeptide growth factors and their relation to renal disease.Am. J. Kidney Dis. 14:61–73, 1989.

    Google Scholar 

  28. Kuntz, I. D. Structure-based strategies for drug design and discovery.Science 257:1078–1082, 1992.

    Article  PubMed  CAS  Google Scholar 

  29. Langer, R., and J. P. Vacanti. Tissue engineering.Science 260:920–926, 1993.

    Article  PubMed  CAS  Google Scholar 

  30. Lauffenburger, D. A., and C. Cozens. Regulation of mammalian cell growth by autocrine growth factors: Analysis of consequences for inoculum cell density effects.Biotech. Bioeng. 33:1365–1378, 1989.

    Article  CAS  Google Scholar 

  31. Lauffenburger, D. A., and J. J. Linderman. Receptors: Models for Binding, Trafficking and Signaling. New York: Oxford University Press, 1993.

    Google Scholar 

  32. Luyten, W. H. M. L., and J. E. Leysen. Receptor cloning and heterologous expression—Towards a new tool for drug discovery.Trends Biotech. 11:247–254, 1993.

    Article  CAS  Google Scholar 

  33. Massia, S., and J. Hubbell. Covalent surface immobilization of arg-gly-asp- and tyr-ile-gly-ser-arg-containing peptides to obtain well-defined cell-adhesive substrates.Anal. Biochem. 187:292–301, 1990.

    Article  PubMed  CAS  Google Scholar 

  34. McGeady, M. L., S. Kerby, V. Shankar, F. Ciardiello, D. Salomon, and M. Seidman. Infection with a TGFα retroviral vector transforms ordinary mouse mammary epithelial cells but not normal rat fibroblasts.Oncogene 4:1375–1382, 1989.

    PubMed  CAS  Google Scholar 

  35. Mendelsohn, J. Anti-epidermal growth factor receptor monoclonal antibodies as potential anti-cancer agents.J. Steroid Biochem. Mol. Biol. 37:889–892, 1990.

    Article  PubMed  CAS  Google Scholar 

  36. Meyer-Ingold, W. Wound therapy: Growth factors as agents to promote healing.Trends Biotech. 11:387–392, 1993.

    Article  CAS  Google Scholar 

  37. Modjtahedi, H., J. Styles, and C. Dean. The growth response of human tumour cell lines expressing the EGF receptor to treatment with EGF and/or Mabs that block ligand binding.Int. J. Oncol. 3:237–243, 1993.

    CAS  Google Scholar 

  38. Morgan, R. A., and W. F. Anderson. Human gene therapy.Annu. Rev. Biochem. 62:191–217, 1993.

    Article  PubMed  CAS  Google Scholar 

  39. Moses, M., and R. Langer. Inhibitors of angiogenesis.Bio/Tech. 9:630–634, 1991.

    Article  CAS  Google Scholar 

  40. Northrup, S. H., S. A. Allison, and J. A. McCammon. Brownian dynamics simulation of diffusion-influenced bimolecular reactions.J. Chem. Phys. 80:1517–1524, 1984.

    Article  CAS  Google Scholar 

  41. Powell, E., M. R. Sobarzo, and W. M. Saltzman. Controlled release of nerve growth factor from a polymeric implant.Brain Res. 515:309–311, 1990.

    Article  PubMed  CAS  Google Scholar 

  42. Ratner, B. D. New ideas in biomaterials science—A path to engineered biomaterials.J. Biomed. Mat. Res. 27:837–850, 1993.

    Article  CAS  Google Scholar 

  43. Robb, R. J. Human T-cell growth factor: Purification, biochemical characterization, and interaction with a cellular receptor.Immunobiology 161:21–50, 1982.

    PubMed  CAS  Google Scholar 

  44. Rodeck, U., N. Williams, U. Murthy, and M. Herlyn. Monoclonal antibody 425 inhibits growth stimulation of carcinoma cells by exogenous EGF and tumor-derived EGF/TGFα.J. Cell. Biochem. 44:69–79, 1990.

    Article  PubMed  CAS  Google Scholar 

  45. Ross, R. The pathogenesis of atherosclerosis: An update.New Engl. J. Med. 314:488–500, 1986.

    Article  PubMed  CAS  Google Scholar 

  46. Ross, R. The pathogenesis of atherosclerosis: a perspective for the 1990s.Nature 362:801–809, 1993.

    Article  PubMed  CAS  Google Scholar 

  47. Sieff, C. A. Biology and clinical aspects of the hematopoietic growth factors.Annu. Rev. Med. 41:483–496, 1990.

    Article  PubMed  CAS  Google Scholar 

  48. Sporn, M. B., and A. B. Roberts. Peptide growth factors and inflammation, tissue repair, and cancer.J. Clin. Invest. 78:329–332, 1986.

    Article  PubMed  CAS  Google Scholar 

  49. Sporn, M. B., and A. B. Roberts. Peptide growth factors are multifunctional.Nature 332:217–219, 1988.

    Article  PubMed  CAS  Google Scholar 

  50. Sporn, M. B., and A. B. Roberts. Autocrine secretion—10 years later.Ann. Intern Med. 117:408–414, 1992.

    PubMed  CAS  Google Scholar 

  51. Sporn, M. B., and G. J. Todaro. Autocrine secretion and malignant transformation of cells.New Engl. J. Med. 303: 878–880, 1980.

    Article  PubMed  CAS  Google Scholar 

  52. Springer, T. A. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm.Cell 76: 301–314, 1994.

    Article  PubMed  CAS  Google Scholar 

  53. ten Dijke, P, and K. K. Iwata. Growth factors for wound healing.Bio/tech. 7:793–797, 1989.

    Article  Google Scholar 

  54. Tranquillo, R., M. Durrani, and A. Moon. Tissue engineering science: Consequences of cell traction force.Cytotechnology 10:225–250, 1992.

    Article  PubMed  CAS  Google Scholar 

  55. Wiley, H. S. Receptors: Topology, dynamics, and regulation. In: Membrane Dynamics and Signaling, edited by E. Bittner. JAI Press, 1992, pp. 113–142.

  56. Wiley, H. S., J. J. Herbst, B. J. Walsh, D. A. Lauffenburger, M. G. Rosenfeld, and G. N. Gill. Role of tyrosine kinase activity in endocytosis, compartmentation, and downregulation of the EGF-receptor.J. Biol. Chem. 266: 11083–11094, 1991.

    PubMed  CAS  Google Scholar 

  57. Yamada, Y., and G. Serrero. Autocrine growth induced by the insulin-related factor in the insulin-dependent teratoma cell line 1246-3A.Proc. Natl. Acad. Sci. USA 85:5936–5940, 1988.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Chemical Engineering, University of Illinois at Urbana-Champaign, Urbana, IL

    D. A. Lauffenburger & K. E. Forsten

  2. Department of Cell & Structural Biology, University of Illinois at Urbana-Champaign, Urbana, IL

    D. A. Lauffenburger

  3. Department of Pathology, University of Utah, Salt Lake City, UT

    B. Will & H. S. Wiley

Authors
  1. D. A. Lauffenburger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. E. Forsten
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. Will
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. S. Wiley
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lauffenburger, D.A., Forsten, K.E., Will, B. et al. Molecular/cell engineering approach to autocrine ligand control of cell function. Ann Biomed Eng 23, 208–215 (1995). https://doi.org/10.1007/BF02584423

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02584423

Keywords

Search

Navigation